Is Mid-morning Breakfast as Healthy as Early-morning Breakfast for Blood Sugar Control in Adolescent Girls?

NCT05000944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-10-05

No results posted yet for this study

Summary

Repeated, elevated levels of glucose (sugar) within the blood after eating can lead to type 2 diabetes. In adults, eating breakfast lowers blood glucose responses to subsequent meals when compared with skipping breakfast. Yet, adolescent girls may respond differently due to differences in how their bodies use energy. This is important because around 80% of the United Kingdom (UK) adolescent girls skip breakfast. As common reasons for skipping breakfast in adolescent girls are 'lack of time' and 'not hungry' in the morning, eating breakfast during the mid-morning may be an attractive option for them. This project will be the first to compare the impact of eating breakfast in the early morning and mid-morning with skipping breakfast on subsequent blood glucose levels in adolescent girls who usually skip breakfast. The findings will inform recommendations tailored to an 'at risk' and under-researched population for type 2 diabetes prevention, which is more effective than a cure.

Conditions

  • Postprandial Hyperglycemia

Interventions

OTHER

breakfast omission (BO)

this group will not be provided with a breakfast until lunch time (at 12:30).

OTHER

early-morning breakfast consumption (EM-BC)

this group will be provided with an early morning breakfast (at 08:30).

OTHER

mid-morning breakfast consumption (MM-BC)

this group will be provided with a mid (late) morning breakfast (at 10:30).

Sponsors & Collaborators

  • University of Bedfordshire

    collaborator OTHER
  • Loughborough University

    lead OTHER

Principal Investigators

  • Keith Tolfrey, Dr · Loughborough University

  • Sahar Afeef, MSc · Loughborough University

  • Julia Zakrzewski-Fruer, Dr · University of Bedfordshire

  • Laura Barrett, Dr · Loughborough University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
11 Years
Max Age
14 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-18
Primary Completion
2022-07-13
Completion
2022-07-13

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05000944 on ClinicalTrials.gov